Omnicell, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-86.0% vs price
Base Case (Median)
-43.3% vs price
Bull Case (75th pct.)
-37.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-2.07 | -105.7% | High (40%) |
| PE Comparable | $18.69 | -48.1% | Medium (25%) |
| Graham Number | $22.51 | -37.5% | Medium (40%) |
| EV/EBITDA | $22.16 | -38.5% | Medium (20%) |
| EV/FCF | $61.53 | 70.8% | Medium (20%) |
| Earnings Power Value | $0.50 | -98.6% | Medium (50%) |
Based on 6 out of 8 methods, OMCL appears overvalued at the current price of $36.03. The base case fair value of $20.43 implies 43.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.